Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transplantation

M A Hardy1, R S Sung

  • 1Columbia University College of Physicians and Surgeons, New York, NY, USA.

JAMA
|June 7, 1995
PubMed
Summary
This summary is machine-generated.

Multicenter studies found no evidence of cyclosporine-induced kidney damage. Researchers explored donor-specific bone marrow transplantation to improve organ transplant success by reducing immune rejection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predicting Primary Nonfunction of Liver Transplants With Laboratory Values: Can It Be Done?

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017
Same author

Gene Expression in Biopsies of Acute Rejection and Interstitial Fibrosis/Tubular Atrophy Reveals Highly Shared Mechanisms That Correlate With Worse Long-Term Outcomes.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2016
Same author

What's hot, what's new in clinical organ transplantation: report from the American Transplant Congress 2015.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2015
Same author

Kidneys at higher risk of discard: expanding the role of dual kidney transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2014
Same author

Simultaneous liver-kidney transplantation summit: current state and future directions.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2012
Same author

Availability, utilization and outcomes of deceased diabetic donor kidneys; analysis based on the UNOS registry.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2012
Same journal

WHO Issues Guidelines for Treating Ebola and Marburg Viruses.

JAMA·2026
Same journal

FDA Approves Additional Naloxone Nasal Spray for Opioid Overdose.

JAMA·2026
Same journal

HIV May Hide in More Cells Than Previously Thought-Here's What That Could Mean for a Cure.

JAMA·2026
Same journal

US Dietary Supplement Use Increasing, Especially in Older Adults.

JAMA·2026
Same journal

Heat Stress From Climate Change Surges Globally.

JAMA·2026
Same journal

Strength Training Linked With Lower Cardiovascular Disease Risk in Women.

JAMA·2026
See all related articles

Area of Science:

  • Nephrology
  • Transplantation Immunology

Background:

  • Concerns about cyclosporine's nephrotoxicity have been raised.
  • Cyclosporine is a common immunosuppressant in organ transplantation.

Purpose of the Study:

  • To evaluate the nephrotoxicity of cyclosporine in multicenter studies.
  • To assess the efficacy of perioperative donor-specific bone marrow transplantation in inducing tolerance to allografts.

Main Methods:

  • Conducted multicenter studies to monitor kidney function in patients receiving cyclosporine.
  • Implemented perioperative donor-specific bone marrow transplantation protocols in human organ transplantation.

Main Results:

  • Multicenter studies did not substantiate concerns regarding cyclosporine-induced nephrotoxicity.

Related Experiment Videos

  • Perioperative donor-specific bone marrow transplantation has been utilized in human organ transplantation.

    • Conclusions:

    • Current evidence does not support significant nephrotoxicity concerns with cyclosporine.
    • Donor-specific bone marrow transplantation shows promise for inducing unresponsiveness to allografts, potentially improving transplant outcomes.